Genetic Analysis of GRIK2's Role in Huntington's Disease
Author Information
Author(s): Zeng Wenqi, Gillis Tammy, Hakky Michael, Djoussé Luc, Myers Richard H, MacDonald Marcy E, Gusella James F
Primary Institution: Massachusetts General Hospital
Hypothesis
Does the 16 TAA allele of the GRIK2 gene influence the age of neurological onset in Huntington's disease?
Conclusion
The study suggests that the TAA repeat itself is responsible for modifying the age of onset in Huntington's disease.
Supporting Evidence
- The study involved sequencing GRIK2 in individuals with earlier than expected onset of Huntington's disease.
- A significant association was found between the 16 TAA allele and a younger age at onset.
- The research confirmed that the TAA repeat itself, rather than a linked polymorphism, is responsible for the modifier effect.
Takeaway
This study looks at a gene called GRIK2 to see if a specific part of it can change when people start showing symptoms of Huntington's disease. They found that a certain repeat in the gene seems to make symptoms start earlier.
Methodology
The study sequenced all GRIK2 exons and analyzed genetic variations in individuals with Huntington's disease.
Limitations
The study did not find coding sequence variants that could explain the modifier effect, suggesting other factors may be involved.
Participant Demographics
Participants included individuals with Huntington's disease, specifically those with known CAG repeat lengths.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website